title: Estimated effect of asthma case management using propensity score methods.
abstract: OBJECTIVE
  To estimate the treatment effect of participation in an asthma intervention that was part of the National Asthma Control Program.
  
  
  METHODS
  Cross-sectional; difference in outcomes between participants and comparable nonparticipants matched by using propensity scores.
  
  
  METHODS
  Data on children who participated in asthma case management (n = 270) and eligible children who did not participate in case management (n = 2742) were extracted from a Medicaid claims database. We constructed measures of healthcare utilization, sociodemographics, and neighborhood characteristics. After creating a comparison group similar to the participants in terms of all characteristics before participation, we estimated the effect of the program on asthma outcomes.
  
  
  RESULTS
  Participants were more likely to have vaccinations for pulmonary illness (95% confidence interval [CI] = 1.82, 4.81), to fill a prescription for controller medications (95% CI = 1.07, 2.19), and to have a refill for rescue medication (95% CI = 1.07, 2.07) after the program than comparable nonparticipants. There was no statistically significant difference in the number of nebulizer treatments or emergency department visits between the 2 groups.
  
  
  CONCLUSIONS
  The program did increase the use of preventive healthcare by participants. Over the time period we studied, these behaviors did not decrease healthcare utilization for asthma exacerbations. We were unable to discern whether the lack of effect was because of the nature of the program, heterogeneity of the effects, or barriers outside the program's control.
authors.affiliation: Department of Resource Economics, University of Massachusetts - Amherst, MA 01003, USA. brandt@resecon.umass.edu
authors.forename: Sylvia
authors.initials: S
authors.lastname: Brandt
authors.forename: Sara
authors.initials: S
authors.lastname: Gale
authors.forename: Ira B
authors.initials: IB
authors.lastname: Tager
mesh_terms: D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000628:therapy*; D002140:California; D019090:Case Management; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008484:Medicaid / Q000706:statistics & numerical data; D017063:Outcome Assessment, Health Care; D010353:Patient Education as Topic; D015397:Program Evaluation; D057216:Propensity Score; D012111:Residence Characteristics; D016896:Treatment Outcome; D014481:United States; D055815:Young Adult
chemical_list: D018927:Anti-Asthmatic Agents